Annual EBIT
-$107.91 M
+$9.23 M+7.88%
31 December 2023
Summary:
Foghorn Therapeutics annual earnings before interest & taxes is currently -$107.91 million, with the most recent change of +$9.23 million (+7.88%) on 31 December 2023. During the last 3 years, it has fallen by -$40.09 million (-59.10%). FHTX annual EBIT is now -315.57% below its all-time high of -$25.59 million.FHTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$23.85 M
+$382.00 K+1.58%
30 September 2024
Summary:
Foghorn Therapeutics quarterly earnings before interest & taxes is currently -$23.85 million, with the most recent change of +$382.00 thousand (+1.58%) on 30 September 2024. Over the past year, it has dropped by -$6.77 million (-39.64%). FHTX quarterly EBIT is now -83.77% below its all-time high of -$12.98 million, reached on 30 September 2019.FHTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$101.74 M
-$6.77 M-7.13%
30 September 2024
Summary:
Foghorn Therapeutics TTM earnings before interest & taxes is currently -$101.74 million, with the most recent change of -$6.77 million (-7.13%) on 30 September 2024. Over the past year, it has increased by +$12.60 million (+11.02%). FHTX TTM EBIT is now -683.87% below its all-time high of -$12.98 million, reached on 30 September 2019.FHTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FHTX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.9% | -39.6% | +11.0% |
| 3 y3 years | -59.1% | +6.8% | -11.6% |
| 5 y5 years | -315.6% | -83.8% | -683.9% |
FHTX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -59.1% | +7.9% | -39.6% | +28.4% | -11.6% | +18.9% |
| 5 y | 5 years | -315.6% | +7.9% | -83.8% | +28.4% | -683.9% | +18.9% |
| alltime | all time | -315.6% | +7.9% | -83.8% | +28.4% | -683.9% | +18.9% |
Foghorn Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$23.85 M(-1.6%) | -$101.74 M(+7.1%) |
| June 2024 | - | -$24.23 M(-14.0%) | -$94.97 M(-7.6%) |
| Mar 2024 | - | -$28.19 M(+10.7%) | -$102.78 M(-4.7%) |
| Dec 2023 | -$107.91 M(-7.9%) | -$25.46 M(+49.0%) | -$107.91 M(-5.6%) |
| Sept 2023 | - | -$17.08 M(-46.7%) | -$114.33 M(-8.9%) |
| June 2023 | - | -$32.05 M(-3.8%) | -$125.51 M(+2.3%) |
| Mar 2023 | - | -$33.32 M(+4.5%) | -$122.65 M(+4.7%) |
| Dec 2022 | -$117.14 M(+17.8%) | -$31.89 M(+12.8%) | -$117.14 M(+2.8%) |
| Sept 2022 | - | -$28.26 M(-3.2%) | -$113.97 M(+2.4%) |
| June 2022 | - | -$29.19 M(+5.0%) | -$111.29 M(+6.3%) |
| Mar 2022 | - | -$27.80 M(-3.2%) | -$104.72 M(+5.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$99.41 M(+46.6%) | -$28.72 M(+12.3%) | -$99.41 M(+9.1%) |
| Sept 2021 | - | -$25.58 M(+13.1%) | -$91.13 M(+8.9%) |
| June 2021 | - | -$22.62 M(+0.5%) | -$83.72 M(+9.3%) |
| Mar 2021 | - | -$22.50 M(+10.1%) | -$76.63 M(+13.0%) |
| Dec 2020 | -$67.82 M(+34.1%) | -$20.44 M(+12.5%) | -$67.82 M(+8.5%) |
| Sept 2020 | - | -$18.16 M(+17.0%) | -$62.50 M(+9.0%) |
| June 2020 | - | -$15.53 M(+13.4%) | -$57.31 M(+37.2%) |
| Mar 2020 | - | -$13.69 M(-9.4%) | -$41.79 M(+48.7%) |
| Dec 2019 | -$50.59 M(+94.8%) | -$15.11 M(+16.4%) | -$28.09 M(+116.4%) |
| Sept 2019 | - | -$12.98 M | -$12.98 M |
| Dec 2018 | -$25.97 M | - | - |
FAQ
- What is Foghorn Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual EBIT year-on-year change?
- What is Foghorn Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly EBIT year-on-year change?
- What is Foghorn Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Foghorn Therapeutics?
- What is Foghorn Therapeutics TTM EBIT year-on-year change?
What is Foghorn Therapeutics annual earnings before interest & taxes?
The current annual EBIT of FHTX is -$107.91 M
What is the all time high annual EBIT for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual earnings before interest & taxes is -$25.59 M
What is Foghorn Therapeutics annual EBIT year-on-year change?
Over the past year, FHTX annual earnings before interest & taxes has changed by +$9.23 M (+7.88%)
What is Foghorn Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of FHTX is -$23.85 M
What is the all time high quarterly EBIT for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly earnings before interest & taxes is -$12.98 M
What is Foghorn Therapeutics quarterly EBIT year-on-year change?
Over the past year, FHTX quarterly earnings before interest & taxes has changed by -$6.77 M (-39.64%)
What is Foghorn Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of FHTX is -$101.74 M
What is the all time high TTM EBIT for Foghorn Therapeutics?
Foghorn Therapeutics all-time high TTM earnings before interest & taxes is -$12.98 M
What is Foghorn Therapeutics TTM EBIT year-on-year change?
Over the past year, FHTX TTM earnings before interest & taxes has changed by +$12.60 M (+11.02%)